3 completed, 1 terminated. 2 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Morphine Dependence: new trials by email Literature Review of Morphine Dependence trials Research Report on Morphine Dependence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS), Cognitive Training - Opioid-Related Disorders, Heroin Dependence | Not applicable | Terminated | University of Minnesota | 9 | 2021-01-11 | 2025-07-10 |
| Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal Dexmedetomidine, Placebo - Opioid Withdrawal | Phase 1 / Phase 2 | Completed | BioXcel Therapeutics Inc | 225 | 2020-06-09 | 2026-08-11 |
| Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1 Buprenorphine/naloxone - Heroin Dependence, Morphine Dependence | Phase 3 | Completed | University of California, Los Angeles | 163 | 2001-02-01 | 2017-01-12 |
| Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1 Buprenorphine/naloxone - Heroin Dependence, Morphine Dependence | Phase 3 | Completed | University of California, Los Angeles | 341 | 2001-01-01 | 2017-01-12 |
Opioid-Related Disorders (4) · Heroin Dependence (3) · Substance Withdrawal Syndrome (2) · Psychomotor Agitation (1)
Chemically-Induced Disorders (4) · Mental Disorders (4) · Narcotic-Related Disorders (4) · Substance-Related Disorders (4) · Aberrant Motor Behavior in Dementia (1) · Behavior (1) · Behavioral Symptoms (1) · Dyskinesias (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Psychomotor Disorders (1) · Signs and Symptoms (1)
Buprenorphine, Naloxone Drug Combination (2) · Cognitive Training (1) · Dexmedetomidine (1) · Transcranial Direct Current Stimulation (1)
University of California, Los Angeles (2) · BioXcel Therapeutics Inc (1) · University of Minnesota (1)
United States (4)
Walter Ling, M.D. (2) · BioXcel MM, MD (1) · Jazmin Camchong, PhD (1) · Kelvin Lim, MD (1)
1UG3DA048508-01 (1)